BetterScholar BetterScholar
8
Role
Title
Level Year L/R
๐Ÿœ Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist
14 auth. D. Nichols, Sarah J. Morgan, M. Skalland, A. Vo, J. V. Van Dalfsen, Sachinkumar Singh, W. Ni, L. Hoffman, Kailee McGeer, S. Heltshe, ... J. Clancy, S. Rowe, Peter Jorth, Pradeep K. Singh
6 2023
6
๐Ÿœ
๐Ÿœ Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI.
21 auth. S. Schwarzenberg, Phuong T. Vu, M. Skalland, L. Hoffman, C. Pope, D. Gelfond, M. Narkewicz, D. Nichols, S. Heltshe, S. Donaldson, ... C. Frederick, A. Kelly, J. Pittman, F. Ratjen, M. Rosenfeld, S. Sagel, G. Solomon, M. Stalvey, J. Clancy, S. Rowe, S. Freedman
5 2022
5
๐Ÿœ
๐Ÿœ Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
201 auth. N. Mayer-Hamblett, F. Ratjen, R. Russell, S. Donaldson, K. Riekert, G. Sawicki, K. Odem-Davis, Julia K Young, D. Rosenbluth, J. Taylor-Cousar, C. Goss, G. Retsch-Bogart, J. Clancy, A. Genatossio, B. O'sullivan, ... A. Berlinski, S. Millard, G. Omlor, Colby A. Wyatt, K. Moffett, D. Nichols, A. Gifford, M. Kloster, Katie Weaver, C. Chapdu, Jing Xie, M. Skalland, Melita Romasco, S. Heltshe, N. Simon, J. Vandalfsen, A. Mead, Rachael Buckingham, Kathy Seidel, Nikita Midamba, L. Couture, Brooke Zappone Case, Wendy Au, Elsie Rockers, D. Cooke, Amber Olander, I. Bondick, Miya Johnson, Lisya VanHousen, B. Nicholson, Michelle Parrish, D. Roberts, J. Head, J. Carey, Lindsay J. Caverly, Joy Dangerfield, Rachel W. Linnemann, J. Fullmer, Chelsea Roman, P. Mogayzel, D. Reyes, Amy Harmala, J. Lysinger, Jonathan M. Bergeron, I. Virella-Lowell, P. Brown, L. Godusevic, Alicia Casey, Laure Paquette, T. Lahiri, J. Sweet, S. Donaldson, Joshua Harris, Shelia Parnell, S. Szentpetery, D. Froh, E. Tharrington, Manu Jain, R. Nelson, Sharon Kadon, Gary McPhail, Kimberly McBennett, Tia Rone, E. Dasenbrook, David Weaver, T. Johnson, K. McCoy, R. Jain, Marian B. Mcleod, M. Klosterman, P. Sharma, Amy Jones, Gary Mueller, Rachel E. Janney, J. Taylor-Cousar, M. Cross, J. Hoppe, James Cahill, Z. Mukadam, Jill Finto, K. Schultz, Silvia Delgado Villalta, A. Smith, S. Millard, T. Symington, G. Graff, D. Kitch, D. Sanders, M. Thompson, Tahuanty A. Peรฑa, Mary E. Teresi, Jennifer Gafford, D. Schaeffer, J. Mermis, Lorne Scott, Hugo Escobar, Kristen Williams, Dana B. Dorman, B. O'sullivan, Ryan Bethay, Zoran Danov, Katherine Turbeville, J. Johannes, Angelica Rodriguez, B. Marra, R. Zanni, Robert W Morton, Terri Simeon, Andrew Braun, Nicole Dondlinger, J. Biller, E. Hubertz, Nicholas Antos, Laura Roth, J. Billings, Catherine Larson, P. Balaji, J. McNamara, Tammy Clark, Rebecca S. Griffith, N. Martinez, Sabiha Hussain, Halina Malveaux, Marie Egan, Catalina Guzmรกn, Joan DeCelie-Germana, Susan Galvin, A. Savant, N. Falgout, Patricia A. Walker, T. DeMarco, E. DiMango, M. Ycaza, Julie Ballo, Pornchai Tirakitsoontorn, D. Layish, Desiree Serr, Floyd Livingston, Sherry Wooldridge, C. Milla, J. Spano, Rebecca Davis, O. Elidemir, S. Chittivelu, A. Scott, Sarah Alam, D. Dorgan, Matt Butoryak, Daniel Weiner, Harmony Renna, Colby A. Wyatt, Brendan D Klein, A. Stone, Margaret Lessard, M. Schechter, Barbara Johnson, Steve Scofield, T. Liou, J. Vroom, K. Akong, M. Gil, L. Betancourt, Jonathan A. Singer, N. Ly, C. Moreno, M. Aitken, T. Gambol, R. Gibson, Allison Lambert, J. Milton, Sarah Smith, Deanna M. Green, D. Hodge, C. Fortner, M. Forell, R. Karlnoski, Kapil M. Patel, Cori Daines, Elizabeth Ryan, R. Amaro-Galvez, E. Dohanich, A. Lennox, Z. Messer, Holly Hanes, Kay Powell, Deepika Polineni
5 2022
5
๐Ÿœ
๐Ÿœ Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
8 auth. D. Nichols, K. Odem-Davis, J. Cogen, C. Goss, C. Ren, M. Skalland, ... R. Somayaji, S. Heltshe
5 2020
5
๐Ÿœ
๐Ÿœ A Randomized Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.
11 auth. C. Goss, S. Heltshe, N. West, M. Skalland, D. Sanders, R. Jain, ... T. Barto, B. Fogarty, B. Marshall, D. VanDevanter, P. Flume
5 2021
5
๐Ÿœ
๐Ÿฌ Ivacaftor-treated Patients with Cystic Fibrosis Derive Long-Term Benefit Despite No Short-Term Clinical Improvement.
S. Heltshe, S. Rowe, M. Skalland, A. Baines, M. Jain
4 2017
4
๐Ÿฌ
๐Ÿœ Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening
8 auth. D. Gelfond, S. Heltshe, M. Skalland, J. Heubi, M. Kloster, D. Leung, ... B. Ramsey, D. Borowitz
4 2017
4
๐Ÿœ
๐Ÿœ Measuring the impact of CFTR modulation on sweat chloride in cystic fibrosis: Rationale and design of the CHEC-SC study.
8 auth. E. Zemanick, M. Konstan, D. VanDevanter, S. Rowe, J. Clancy, K. Odem-Davis, ... M. Skalland, N. Mayer-Hamblett
4 2021
4
๐Ÿœ